Voloridge Investment Management’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-162,315	Closed	-$7.08M	–	1288
2025 Q2	$7.08M	Buy	162,315 +18,091	+13%	+$623K	0.03%	655
2025 Q1	$3.95M	Sell	144,224 -3,014	-2%	-$110K	0.01%	838
2024 Q4	$5.92M	Sell	147,238 -87,533	-37%	-$3.95M	0.02%	726
2024 Q3	$11.1M	Sell	234,771 -38,748	-14%	-$1.71M	0.04%	555
2024 Q2	$8.16M	Buy	273,519 +6,005	+2%	+$208K	0.03%	619
2024 Q1	$10.8M	Buy	267,514 +25,716	+11%	+$920K	0.04%	476
2023 Q4	$6.16M	Buy	241,798 +114,983	+91%	+$2.06M	0.02%	574
2023 Q3	$1.76M	Sell	126,815 -88,392	-41%	-$1.78M	0.01%	957
2023 Q2	$4.95M	Sell	215,207 -36,154	-14%	-$1.04M	0.02%	674
2023 Q1	$7.45M	Buy	251,361 +111,473	+80%	+$3.6M	0.04%	548
2022 Q4	$3.49M	Sell	139,888 -43,831	-24%	-$1.17M	0.02%	784
2022 Q3	$4M	Buy	183,719 +11,447	+7%	+$302K	0.02%	731
2022 Q2	$3.39M	Buy	+172,272	New	+$4.02M	0.02%	817
2021 Q3	–	Sell	-48,460	Closed	-$2.35M	–	1758
2021 Q2	$2.35M	Sell	48,460 -50,905	-51%	-$2.21M	0.02%	932
2021 Q1	$3.86M	Buy	+99,365	New	+$5.98M	0.03%	607